Loading...

Cryosite Limited

CTE.AX•ASX
HealthcareMedical - Diagnostics & Research
A$0.74
A$0.00(0.00%)

Cryosite Limited (CTE.AX) Stock Overview

Explore Cryosite Limited’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
5.67%
↑ 5.67%
Profit Growth
A$0.04
↑ 30.59%
EPS Growth
A$0.04
↑ 30.45%
Operating Margin
17.33%
↑ 34.78%
ROE
132.75%
↑ 30.59%
Dividend Yield
0.00%
↑ 50.00%
Analyst Recommendations data is not available for CTE.AXAnalyst Recommendations details for CTE.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns management, comparator sourcing, import, export, validated transport, and biological storage solutions to the clinical trials, and research and pharmaceutical industry. The Cord Blood and Tissues Storage segment offers long term storage solutions for cord blood and tissue samples. It serves research, medical, pharmaceutical, veterinary, and biotechnology industries. The company was incorporated in 1999 and is based in South Granville, Australia.

CEO

Ms. Jane Hao

Employees

25

Headquarters

13a Ferndell Street, South Granville, NSW

Founded

2002

Frequently Asked Questions